Ligand Acquires Neurogen and Access to Merck Partnership
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 9 (Table of Contents)
Published: 4 Sep-2009
DOI: 10.3833/pdr.v2009.i9.1230 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Ligand Pharmaceuticals will acquire Neurogen Corporation by swapping shares valued at US$11 M and granting contingent value rights (CVRs) based on certain asset sales and achieving milestones in two programmes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS